Date: 10-Aug-2019

Lilly Evidation Health and Apple study shows personal digital devices may help in the identification of mild cognitive impairment and mild Alzheimers

Initial results from a feasibility study conducted by Eli Lilly and Company (NYSE: LLY), Evidation Health, and Apple Inc. (NASDAQ: AAPL) showed that an iPhone, Apple Watch, iPad and the Beddit sleep monitoring device, in combination with digital apps may be able to differentiate people with mild cognitive impairment (MCI) and mild Alzheimers disease dementia. (1) The exploratory results were presented at the Association for Computing Machinerys KDD conference in Anchorage, and are published on the conference website as one of the top papers of the conference